With the now large number of institutional investors waiting for the end game, they, I assume, are not interested in the day to day volatility and possibly are happy to lend their shares to shorters. With a small volumes creating big swings in the market cap, it seems a reasonable share to do this with, particularly with the positive trial news coming out at predictable times and scant updates inbetween.
Being in it for the long term, I just have to learn not to stress about the day to day prices and hold onto the faith that eventually there will be a result that leads us to FDA approval.
VLA Price at posting:
80.0¢ Sentiment: Buy Disclosure: Held
